Publication

Byline

Location

US Patent Issued to University of Florida Research Foundation on April 21 for "Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer" (Florida Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,445, issued on April 21, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Hematopoietic stem cells in ... और पढ़ें


US Patent Issued to The Methodist Hospital on April 21 for "PSMA-targeted immunotherapies for cancers" (Texas Inventor)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,446, issued on April 21, was assigned to The Methodist Hospital (Houston). "PSMA-targeted immunotherapies for cancers" was invented by Bin... और पढ़ें


US Patent Issued to ITM Solucin on April 21 for "Stable formulations for radionuclide complexes" (German, Italian Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,447, issued on April 21, was assigned to ITM Solucin GmbH (Garching bei Munchen, Germany). "Stable formulations for radionuclide complexes... और पढ़ें


US Patent Issued to REGENTS OF THE UNIVERSITY OF MICHIGAN on April 21 for "Porous self-healing polymer matrix for encapsulation of active macromolecules and methods" (Michigan, New Jersey Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,448, issued on April 21, was assigned to REGENTS OF THE UNIVERSITY OF MICHIGAN (Ann Arbor, Mich.). "Porous self-healing polymer matrix for... और पढ़ें


US Patent Issued to Korea Institute of Geoscience and Mineral Resources on April 21 for "Drug-clay mineral complex containing phospholipid and oral administration composition including same" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,449, issued on April 21, was assigned to Korea Institute of Geoscience and Mineral Resources (Daejeon, South Korea). "Drug-clay mineral co... और पढ़ें


US Patent Issued to C4 THERAPEUTICS on April 21 for "C3-carbon linked glutarimide Degronimers for target protein degradation" (Colorado, Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,450, issued on April 21, was assigned to C4 THERAPEUTICS INC. (Watertown, Mass.). "C3-carbon linked glutarimide Degronimers for target pro... और पढ़ें


US Patent Issued to Novartis on April 21 for "Targeted plasma protein degradation" (Massachusetts Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,451, issued on April 21, was assigned to Novartis AG (Basel, Switzerland). "Targeted plasma protein degradation" was invented by Martin Al... और पढ़ें


US Patent Issued to Regents of the University of Minnesota, Regents of the University of California on April 21 for "Compounds that degrade kinases and uses thereof" (Minnesota, California Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,452, issued on April 21, was assigned to Regents of the University of Minnesota (Minneapolis) and Regents of the University of California (... और पढ़ें


US Patent Issued to Industry-University Cooperation Foundation Hanyang University, Konkuk University Glocal Industry-Academic Collaboration Foundation, Korea National University of Education Industry-Academy Cooperation Foundation on April 21 for "CP2C-targeting peptide-based anticancer agent" (South Korean Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,453, issued on April 21, was assigned to Industry-University Cooperation Foundation Hanyang University (Seoul, South Korea), Konkuk Univers... और पढ़ें


US Patent Issued to SAIBA on April 21 for "Modified virus-like particles of CMV" (Latvian, Swiss Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,454, issued on April 21, was assigned to SAIBA AG (Pfaffikon, Switzerland). "Modified virus-like particles of CMV" was invented by Martin ... और पढ़ें